N. Bhasin, M. Kumar Sharma, D. N. Yadav, and D. M. Kumar Kumawat, “Diabetes Ketoacidosis Is a Cause of Concern in Sodium-Glucose Co-Transporter-2 Inhibitors Medication: Pharmaceutical Science-Pharmaceutics”, Int J Life Sci Pharm Res, vol. 13, no. SP 1, pp. P55-P67, Dec. 2022.